GS
Therapeutic Areas
CEL-SCI Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Multikine (Leukocyte Interleukin, Injection) | Advanced Primary Head and Neck Cancer | Phase 3 |
| LEAPS Technology | Rheumatoid Arthritis | Pre-clinical |
Leadership Team at CEL-SCI
GR
Geert R. Kersten
Director and Chief Executive Officer
ET
Eyal Talor, Ph.D.
Chief Scientific Officer
PB
Patricia B. Prichep
Chief Financial and Operations Officer
JC
John Cipriano
Senior Vice President of Regulatory Affairs
W"
William "Brooke" Jones
Quality Assurance Advisor